Advanced search

Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension

(1992) In AMERICAN JOURNAL OF HYPERTENSION 5(suppl.). p.95A-95A
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Delanghe, Joris, Daniel Duprez, MARC DE BUYZERE, Geert Leroux-Roels, and Denis Clement. 1992. “Haptoglobin 2-2, a Genetic Marker for Therapy Resistance in Established Essential Hypertension.” In , 5:95A–95A.
APA
Delanghe, Joris, Duprez, D., DE BUYZERE, M., Leroux-Roels, G., & Clement, D. (1992). Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension (Vol. 5, p. 95A–95A).
Vancouver
1.
Delanghe J, Duprez D, DE BUYZERE M, Leroux-Roels G, Clement D. Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension. 1992. p. 95A–95A.
MLA
Delanghe, Joris, Daniel Duprez, MARC DE BUYZERE, et al. “Haptoglobin 2-2, a Genetic Marker for Therapy Resistance in Established Essential Hypertension.” Vol. 5. 1992. 95A–95A. Print.
@inproceedings{224595,
  author       = {Delanghe, Joris and Duprez, Daniel and De Buyzere, Marc and Leroux-Roels, Geert and Clement, Denis},
  issn         = {0895-7061},
  language     = {eng},
  number       = {suppl.},
  pages        = {95A--95A},
  title        = {Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension},
  volume       = {5},
  year         = {1992},
}